Urinary C3dg and C5b-9 indicate active immune disease in human membranous nephropathy
- 1 April 1992
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 41 (4), 933-937
- https://doi.org/10.1038/ki.1992.143
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Fluid phase generation of terminal complement complex as a novel index of bioincompatibilityKidney International, 1990
- Urinary excretion of C5b-9 reflects disease activity in passive Heymann nephritisKidney International, 1989
- Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the ratKidney International, 1989
- Complement and the direct mediation of immune glomerular injury: A new perspectiveKidney International, 1985
- Radioimmunoassay of the Attack Complex of Complement in Serum from Patients with Systemic Lupus ErythematosusNew England Journal of Medicine, 1985
- Demonstration of C3d Deposits in Membranous NephropathyNephron, 1984
- Use of Single Voided Urine Samples to Estimate Quantitative ProteinuriaNew England Journal of Medicine, 1983
- Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.Journal of Clinical Investigation, 1983
- Measurement of the complement C3 breakdown product C3d by rocket immunoelectrophoresisJournal of Immunological Methods, 1982
- IMMUNE-COMPLEX GLOMERULOPATHY IN PATIENTS TREATED WITH CAPTOPRILThe Lancet, 1980